[ad_1]
FILE PHOTO: A woman holds a small bottle labeled with a “COVID-19 Coronavirus Vaccine” sticker and a medical syringe in front of the Pfizer logo shown in this illustration taken on October 30, 2020. REUTERS / Dado Ruvic / File Photo
Vaccine developers Pfizer Inc and Moderna Inc on Monday declined an invitation from US President Donald Trump to attend a “Vaccine Summit” at the White House.
The meeting, scheduled for Tuesday, comes ahead of the US Food and Drug Administration (FDA) review of Moderna and Pfizer-BioNTech’s vaccine candidates. It will be attended by Trump, Vice President Mike Pence and executives from the private sector.
Industry officials familiar with the plans for the summit interpret it as an opportunity for the White House to pressure the FDA to quickly issue emergency use authorizations for the two candidate vaccines, Stat News reported last week.
Guests at the meeting include drug distributors, pharmacies and logistics companies such as McKesson Corp, Walgreens Boots Alliance Inc, CVS Health Corp, United Parcel Service Inc, and FedEx Corp.
Stat News reported earlier Tuesday that Pfizer and Moderna would not be attending the summit, citing sources familiar with planning the event.
For more news on the new coronavirus, click here.
What you need to know about the coronavirus.
For more information on COVID-19, call the DOH hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare leaders and still accepts cash donations to be deposited into the Banco de Oro (BDO) checking account # 007960018860 or donate through PayMaya using this link .
Read next
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer and more than 70 other titles, share up to 5 gadgets, listen to the news, download from 4am and share articles on social media. Call 896 6000.
For comments, complaints or inquiries, please contact us.
[ad_2]
